Impact of Representative Payee Services on ART Adherence Among Marginalized People Living With HIV/AIDS
2 other identifiers
interventional
91
1 country
3
Brief Summary
Client-Centered Representative Payee is a structural intervention that provides financial management support to PLWHA by modifying the implementation of a long-standing policy within the Social Security Administration, in which an organization is authorized to serve as the client's payee. The central hypothesis of this study is that by helping clients to pay rent and other bills on time, housing stability will improve and financial stress will decrease. By reducing the cognitive burden of living with chronic financial stress and frequent threats of housing loss, clients can devote more time and attention to medical appointments and medication adherence. It is further hypothesized that these changes will improve clients' self-efficacy for health behaviors, retention in care, medication adherence, and viral loads. These hypotheses will be tested via the following specific aims: (1) Conduct a randomized controlled trial with two randomized arms (n=160) and two non-randomized arms (n=50) to test the effect of Client-Centered Rep Payee on ART adherence and viral load among PLWHA who are economically disadvantaged and unstably housed. Clinical adherence will be compared through behavioral and biological measures including prescription refill data, self-reported appointment adherence, and viral load for patients receiving the intervention versus those receiving standard of care. (2) Test underlying mechanisms associated with Client-Centered Rep Payee that contribute to changes in medication adherence and viral suppression rates. This will be accomplished via use of quantitative (mediation analysis) and qualitative (semi-structured interview) methods to test hypothesized mediators of medication adherence and viral suppression including financial and housing instability, financial stress, self-efficacy for health behaviors, and retention in care. (3) Assess the cost and cost-effectiveness of the Client-Centered Rep Payee model. An economic analysis will be conducted to model the impact of the intervention as compared with standard of care on quality adjusted life years as well as new infections averted. This approach is innovative because it offers a structural intervention to improve adherence by addressing the effects of economic insecurity, requires low financial investment, and can be layered with existing clinical services. Further, it is highly scalable as it builds on a current policy in practice within the Social Security system.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2017
Longer than P75 for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2017
CompletedFirst Submitted
Initial submission to the registry
May 22, 2018
CompletedFirst Posted
Study publicly available on registry
June 19, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2024
CompletedApril 17, 2025
April 1, 2025
6.9 years
May 22, 2018
April 16, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Change in ART Adherence
Change in ART adherence will be calculated by comparing HIV viral load counts at Baseline versus 12 months.
Baseline, 12-months
Secondary Outcomes (15)
Persistence of change in ART Adherence
Baseline plus 12 months versus Baseline plus 24 months.
ART Adherence
Self-report of ART adherence will be measured at Baseline, 6-, and 12-months.
CD4
CD4 will be collected at Baseline, 6-, 12-, 18-, and 24- months.
Self-efficacy for Adherence
Self-efficacy for adherence will be measured at Baseline, 6-, and 12-months.
Retention in Care
Retention in Care will be measured at Baseline, 6-, and 12-months.
- +10 more secondary outcomes
Study Arms (4)
RCT: Intervention
EXPERIMENTALParticipants in the RCT intervention arm will receive client-centered representative payee services in addition to the standard of care.
RCT: Control
NO INTERVENTIONParticipants in the RCT control group will receive the standard of care.
Choice Intervention
EXPERIMENTALParticipants in the Choice intervention arm will receive client-centered representative payee services in addition to the standard of care. They will not be randomly assigned.
Choice Control
NO INTERVENTIONParticipants in the RCT control group will receive the standard of care. They will not be randomly assigned.
Interventions
CCRP is a structural intervention wherein Social Security authorizes a representative payee to serve as financial manager for people who need help managing their money. By helping clients to consistently pay their bills including rents and utilities, CCRP may redirect the expenditure of participants' resources toward improved health behaviors. Shifting the focus of material and biopsychosocial resources may change the context in which health behaviors are produced, contributing to higher rates of adherence and viral suppression. CCRP modifies the implementation of a current policy of the Social Security Administration (SSA) to create an intervention that is highly replicable.
Eligibility Criteria
You may qualify if:
- Living with HIV/AIDS
- years of age and older
- English- or Spanish-speaking
- Recipient of Social Security entitlements (SSI and/or SSDI)
- Income below 138% of the federal poverty level
- One or more of the following: Not virally suppressed (viral suppression is denoted at 200 copies/ml); Unsustained viral suppression over the past 12 months; Poor ART adherence. Poor ART adherence is assessed via a CASE Index Score ≤10 or via a single question to assess the percentages of missed doses in the past week \<90%. (New clients who do not have historical viral load data but are not suppressed at baseline will be eligible for the study if they meet other criteria.)
- Able and willing to provide informed consent
You may not qualify if:
- Currently receiving Representative Payee services or having received them in the past 12 months.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Pittsburghlead
- National Institute of Mental Health (NIMH)collaborator
- University of Alabama at Birminghamcollaborator
Study Sites (3)
Birmingham AIDS Outreach
Birmingham, Alabama, 35294, United States
Action Wellness
Philadelphia, Pennsylvania, 19107, United States
The Open Door, Inc.
Pittsburgh, Pennsylvania, 15233, United States
Related Publications (1)
Olaniyan A, Creasy SL, Batey DS, Brooks MM, Maulsby C, Musgrove K, Hagan E, Martin D, Sashin C, Farmartino C, Hawk M. Protocol of a randomized controlled trial to test the effects of client-centered Representative Payee Services on antiretroviral therapy adherence among marginalized people living with HIV. BMC Public Health. 2020 Sep 23;20(1):1443. doi: 10.1186/s12889-020-09500-z.
PMID: 32967646DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mary E Hawk, DrPH
University of Pittsburgh
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
May 22, 2018
First Posted
June 19, 2018
Study Start
May 1, 2017
Primary Completion
March 31, 2024
Study Completion
March 31, 2024
Last Updated
April 17, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will not share